Nonfasting glucose, ischemic heart disease, and myocardial infarction: a mendelian randomization study
JACC - Journal of the American College of Cardiology, 06/22/2012
Benn M et al. – Like common nonfasting glucose elevation, plasma glucose–increasing polymorphisms associate with increased risk of ischemic heart disease (IHD) and myocardial infarction (MI). These data are compatible with a causal association.